Table 5.
Outcomes in patients with BMI <40, CCI >3.
| Outcome & narcotic usage | Liposomal bupivacaine PAI | No PAI | P value |
|---|---|---|---|
| Length of stay (d) | 3.07 | 3.55 | 0.252 |
| Narcotic use 0-24 h (mg) | 109.8 | 87.5 | 0.283 |
| Narcotic use 24-48 h (mg) | 108.93 | 92.23 | 0.228 |
| Narcotic use 48-72 h (mg) | 75.38 | 68.57 | 0.716 |
| Walking distance POD 1 (ft) | 61.43 | 40.95 | 0.08 |
| Walking distance POD 2 (ft) | 81.64 | 78.23 | 0.828 |
| Walking distance POD 3 (ft) | 82 | 122.1 | 0.176 |
POD, postoperative day; PAI, periarticular injection; BMI, body mass index; CCI, Charlson comorbidity index.